GATA-3 expression identifies a subset of PTCL, NOS with inferior survival. Kaplan-Meier estimates of progression-free and overall survival are shown for PTCL, NOS patients stratified by GATA-3 expression. (GATA3^-, solid line; GATA3⁺, dashed line) A.PFS: progression-free survival; B. OS: Overall survival